WallStSmart
RBOT

Vicarious Surgical Inc.

NYSE: RBOT · HEALTHCARE · MEDICAL DEVICES

$0.60
+3.78% today

Updated 2026-06-04

Market cap
$7.07M
P/E ratio
P/S ratio
EPS (TTM)
$-6.62
Dividend yield
52W range
$0 – $14
Volume
0.0M

Vicarious Surgical Inc. (RBOT) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item2019202020212022202320242025
Operating cash flow$-8.71M$-12.04M$-33.30M$-61.21M$-62.30M$-49.96M$-45.08M
Capital expenditures$246000.00$120000.00$1.29M$5.35M$1.67M$180000.00$132000.00
Depreciation
Stock-based comp$337000.00$448000.00$3.69M$12.26M$13.27M$11.90M$8.13M
Free cash flow$-8.96M$-12.16M$-34.59M$-66.56M$-63.98M$-50.14M$-45.21M
Investing cash flow
Financing cash flow
Dividends paid
Share repurchases
Debt repayment
Net change in cash$-57.42M

Frequently asked questions

How much free cash flow does RBOT generate?

RBOT produced $-45.21M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.